Skull Neoplasms: Clinical Trials

1 trial for Skull Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Skull Neoplasms: new trials by email Literature Review of Skull Neoplasms trials Research Report on Skull Neoplasms

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
autologous EBV specific Cytotoxic T cells, combination IV gemcitabine and IV carboplatin (AUC2) - Nasopharyngeal Carcinoma
Phase 3CompletedTessa Therapeutics3302014-07-012023-06-28

Narrower conditions

Epstein-Barr Virus Infections (1)  ·  Head and Neck Neoplasms (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Nose Neoplasms (1)

Broader conditions

Bone Diseases (1)  ·  Bone Neoplasms (1)  ·  Carcinoma (1)  ·  DNA Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)  ·  Musculoskeletal Diseases (1)  ·  Nasopharyngeal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Nose Diseases (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)

Interventions

Carboplatin (1)

Sponsors

Tessa Therapeutics (1)

Countries

Malaysia (1)  ·  Singapore (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  United States (1)

Results publications

PMID 39241963